SK278865B6 - Interfenylén-7-oxabicykloheptylsubstituované heter - Google Patents

Interfenylén-7-oxabicykloheptylsubstituované heter Download PDF

Info

Publication number
SK278865B6
SK278865B6 SK1582-90A SK158290A SK278865B6 SK 278865 B6 SK278865 B6 SK 278865B6 SK 158290 A SK158290 A SK 158290A SK 278865 B6 SK278865 B6 SK 278865B6
Authority
SK
Slovakia
Prior art keywords
group
formula
mmol
acid
alkyl
Prior art date
Application number
SK1582-90A
Other languages
English (en)
Slovak (sk)
Other versions
SK158290A3 (en
Inventor
Raj Narain Misra
Original Assignee
E. R. Squibb & Sons
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by E. R. Squibb & Sons filed Critical E. R. Squibb & Sons
Publication of SK158290A3 publication Critical patent/SK158290A3/sk
Publication of SK278865B6 publication Critical patent/SK278865B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00—Preparation of halogenated hydrocarbons
    • C07C17/093—Preparation of halogenated hydrocarbons by replacement by halogens
    • C07C17/16—Preparation of halogenated hydrocarbons by replacement by halogens of hydroxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1582-90A 1989-04-03 1990-03-30 Interfenylén-7-oxabicykloheptylsubstituované heter SK278865B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33407089A 1989-04-03 1989-04-03

Publications (2)

Publication Number Publication Date
SK158290A3 SK158290A3 (en) 1998-04-08
SK278865B6 true SK278865B6 (sk) 1998-04-08

Family

ID=23305449

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1582-90A SK278865B6 (sk) 1989-04-03 1990-03-30 Interfenylén-7-oxabicykloheptylsubstituované heter

Country Status (28)

Country Link
EP (1) EP0391652B1 (ja)
JP (1) JP2989213B2 (ja)
KR (1) KR0160508B1 (ja)
CN (1) CN1028529C (ja)
AT (1) ATE119903T1 (ja)
AU (1) AU632797B2 (ja)
CA (1) CA2012267C (ja)
CY (1) CY1851A (ja)
CZ (1) CZ285656B6 (ja)
DD (1) DD293353A5 (ja)
DE (1) DE69017735T2 (ja)
DK (1) DK0391652T3 (ja)
EG (1) EG19080A (ja)
ES (1) ES2069682T3 (ja)
FI (1) FI97543C (ja)
HK (1) HK110495A (ja)
HU (2) HUT54368A (ja)
IE (1) IE67274B1 (ja)
IL (1) IL93771A (ja)
MX (1) MX20132A (ja)
MY (1) MY106245A (ja)
NO (1) NO177425C (ja)
NZ (1) NZ232897A (ja)
PL (1) PL164345B1 (ja)
PT (1) PT93641B (ja)
RU (1) RU2059618C1 (ja)
SK (1) SK278865B6 (ja)
ZA (1) ZA902559B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions
US4977174A (en) * 1989-06-12 1990-12-11 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
ZA911453B (en) * 1990-03-19 1991-11-27 Squibb & Sons Inc Method of protecting against and/or treating ulcerative gastrointestinal conditions using a thromoboxane,a2 receptor antagonist and combination useful in preventing and/or treating ulcers and/or inflammation
US5290799A (en) * 1990-09-19 1994-03-01 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic thioamide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5550248A (en) * 1990-11-29 1996-08-27 E.R. Squibb & Sons, Inc. Substituted stryl heterocyclic amido prostaglandin analogs
US5135939A (en) * 1991-01-28 1992-08-04 E. R. Squibb & Sons, Inc. Heterocyclic ketone prostaglandin analogs
US5238951A (en) * 1991-02-01 1993-08-24 E. R. Squibb & Sons, Inc. Heterocyclic amido prostaglandin analogs
IE920039A1 (en) * 1991-02-01 1992-08-12 Squibb & Sons Inc Heterocyclic amido prostaglandin analogs
US5158967A (en) * 1991-06-12 1992-10-27 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5162352A (en) * 1991-08-22 1992-11-10 E. R. Squibb & Sons, Inc. 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs
CA2081679A1 (en) * 1991-11-27 1993-05-28 Raj N. Misra Gem-dialkyl-7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US5281716A (en) * 1992-06-18 1994-01-25 Bristol-Myers Squibb Company Method for preparing 7-oxabicycloheptyl substituted oxazole amide prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds
US5399725A (en) * 1993-05-27 1995-03-21 Bristol-Myers Squibb Co. 7-oxabicycloheptane carboxylic acid prostaglandin analog intermediates useful in the preparation of anti-thrombotic and anti-vasospastic compounds and method for preparing same
US5539126A (en) * 1994-04-20 1996-07-23 Bristol-Myers Squibb Company Method for preparing homochiral maleimide intermediates, via silylation techniques
US5849766A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Carbamoyl substituted heterocycles
US5849922A (en) * 1996-05-31 1998-12-15 Eli Lilly And Company Preparation of substituted alkenoic acids
US5856584A (en) * 1997-08-06 1999-01-05 The Nutrasweet Company Preparation of 3,3-dimethylbutyraldehyde by oxidation of 3, 3-dimethylbutanol
US5905175A (en) * 1998-05-20 1999-05-18 The Nutrasweet Company Synthesis and purification of 3,3-dimethylbutyraldehyde via oxidation of 1-chloro-3,3-dimethylbutane with dimethyl sulfoxide
US6511999B2 (en) 2000-09-14 2003-01-28 Allergan, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6407250B1 (en) 2000-09-14 2002-06-18 Allergan Sales, Inc. Interphenylene 7-oxabicyclic [2.2.1] heptane oxazoles as prostaglandin F2a antagonists
US6369089B1 (en) 2000-09-14 2002-04-09 Allergan Sales, Inc. Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
FR2838437B1 (fr) * 2002-04-11 2004-06-04 Aventis Pharma Sa Procedes de preparation de combretastatines
US7045634B2 (en) 2003-09-05 2006-05-16 Allergan, Inc. Prostamide receptor antagonists
CA2757480A1 (en) 2009-04-02 2010-10-07 Allergan, Inc. Prostaglandin e receptor antagonists
US20140187596A1 (en) * 2011-05-25 2014-07-03 Allergan, Inc. Fatty acid amide hydrolase inhihibitors for treating pain

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4652576A (en) * 1985-10-18 1987-03-24 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amide-carbamate prostaglandin analogs
US4663337A (en) * 1986-04-18 1987-05-05 E. R. Squibb & Sons, Inc. 7-oxabicycloheptane substituted amides useful in the treatment of thrombotic disease
CA2006355A1 (en) * 1988-12-23 1990-06-23 Philip M. Sher 7-oxabicycloheptyl substituted heterocyclic amide prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
NZ233600A (en) * 1989-06-12 1992-10-28 Squibb & Sons Inc 7-oxabicyclo(2.2.1)heptane imidazole prostaglandin analogs and pharmaceutical compositions

Also Published As

Publication number Publication date
EP0391652A1 (en) 1990-10-10
NO901494L (no) 1990-10-04
EP0391652B1 (en) 1995-03-15
CZ285656B6 (cs) 1999-10-13
FI97543B (fi) 1996-09-30
HK110495A (en) 1995-07-14
KR900016197A (ko) 1990-11-12
PT93641A (pt) 1990-11-20
HU9002048D0 (en) 1990-08-28
CN1028529C (zh) 1995-05-24
FI97543C (fi) 1997-01-10
PL284600A1 (en) 1991-01-14
PL164345B1 (pl) 1994-07-29
AU5206490A (en) 1990-10-04
DE69017735D1 (de) 1995-04-20
NZ232897A (en) 1992-12-23
HU210713A9 (en) 1995-06-28
DK0391652T3 (da) 1995-04-03
CA2012267C (en) 2001-02-27
KR0160508B1 (ko) 1998-12-01
MY106245A (en) 1995-04-29
DD293353A5 (de) 1991-08-29
CN1046163A (zh) 1990-10-17
PT93641B (pt) 1996-06-28
ZA902559B (en) 1991-01-30
FI901645A0 (fi) 1990-04-02
MX20132A (es) 1994-01-31
CA2012267A1 (en) 1990-10-03
CZ158290A3 (cs) 1999-06-16
JP2989213B2 (ja) 1999-12-13
AU632797B2 (en) 1993-01-14
NO177425C (no) 1995-09-20
CY1851A (en) 1996-03-08
NO177425B (no) 1995-06-06
IE901095L (en) 1990-10-03
EG19080A (en) 1994-07-30
NO901494D0 (no) 1990-04-02
RU2059618C1 (ru) 1996-05-10
ES2069682T3 (es) 1995-05-16
IL93771A0 (en) 1990-12-23
SK158290A3 (en) 1998-04-08
IE67274B1 (en) 1996-03-20
DE69017735T2 (de) 1995-08-17
HUT54368A (en) 1991-02-28
ATE119903T1 (de) 1995-04-15
JPH02289579A (ja) 1990-11-29
IL93771A (en) 1995-06-29

Similar Documents

Publication Publication Date Title
SK278865B6 (sk) Interfenylén-7-oxabicykloheptylsubstituované heter
US5100889A (en) 7-oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US6716864B2 (en) Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
DK172411B1 (da) 7-Oxabicycloheptyl-substituerede heterocycliske amid-prostaglandin-analoge samt præparat til inhibering af blodpladeaggregering og bronchokonstriktion
US4522949A (en) 7-Oxabicycloheptane substituted prostaglandin interphenylene analogs useful as cardiovascular agents
US5153327A (en) 7-Oxabicycloheptyl substituted heterocyclic amide or ester prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
US4632931A (en) 7-oxabicycloheptane substituted amide-sulfonamide prostaglandin analogs useful in the treatment of thrombotic disease
US4533673A (en) 7-Oxabicycloheptane substituted enaminone prostaglandin analogs and their use in treatment of thrombolytic disease
US6369089B1 (en) Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2α antagonists
US6043385A (en) Vitamin D derivatives
AU2001292595B2 (en) Interphenylene 7-oxabicyclic[2.2.1]heptane oxazoles as prostaglandin F2a antagonists
US4661506A (en) 7-oxabicycloheptane substituted ox prostaglandin analogs
US4591603A (en) 7-oxabicycloheptane substituted prostaglandin analogs useful in the treatment of thrombotic disease
AU2001290692A1 (en) Interheteroaryl 7-oxabicyclic [2.2.1]heptane oxazoles as prostaglandin F2alpha antagonists
US4575512A (en) 7-Oxabicycloheptane substituted oxa prostaglandin analogs and their anti-thrombotic compositions and methods
JPH04247086A (ja) ７−オキサビシクロヘプチル置換複素環式チオアミドプロスタグランジン類縁体
US5496849A (en) Sulfonic acid derivative and its pharmaceutical application
JP2828334B2 (ja) ノルボルナン系スルホンアミド誘導体の製造方法
EP0497085A1 (en) Heterocyclic ketone prostaglandin analogs
DD299186A5 (de) Phenylen-7-oxabicycloheptyl-substituierte heterocycloamid-prostaglandinanaloga
IL105486A (en) Intermediate compounds for the preparation of anti-hypercholesterolemic compounds